Zevra Therapeutics Inc (ZVRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Operating Expenses | 9,612 | 8,224 | 7,380 | 10,836 | 10,401 |
| Operating Income | -9,612 | -8,224 | -7,380 | -10,836 | -10,401 |
| Interest Expense | 1,839 | 1,833 | 1,831 | 1,836 | 1,831 |
| Other Income | 1,466 | 3,536 | -7,115 | 2,732 | -1,201 |
| Pre-tax Income | -9,985 | -6,521 | -16,326 | -9,940 | -13,433 |
| Income Tax | -4 | -4 | -4 | -12 | -19 |
| Net Income Continuous | -9,981 | -6,517 | -16,322 | -9,928 | -13,414 |
| Net Income | $-9,981 | $-6,517 | $-16,322 | $-9,936 | $-13,414 |
| EPS Basic Total Ops | -10.88 | -7.04 | -17.76 | -9.60 | -14.72 |
| EPS Basic Continuous Ops | -10.90 | -7.12 | -17.83 | -10.91 | -14.65 |
| EPS Diluted Total Ops | -10.88 | -7.04 | -17.76 | 9.12 | -14.72 |
| EPS Diluted Continuous Ops | -10.90 | -7.12 | -17.83 | -10.33 | -14.65 |
| EBITDA(a) | $-9,134 | $-7,750 | $-6,910 | $-10,367 | $-9,969 |